These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6431057)

  • 21. The effect of low dose carbidopa/levodopa on prolactin and growth hormone concentrations in patients with breast cancer and in benign breast tumours.
    Jones MK; Ramsay ID; Jenner PG
    Br J Clin Pharmacol; 1978 May; 5(5):425-30. PubMed ID: 656281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Disturbance of hypothalamic-pituitary hormone secretion in familial chorea-acanthocytosis].
    Terao S; Sobue G; Takahashi M; Miura N; Mitsuma T; Takeda A; Sakakibara T
    No To Shinkei; 1995 Jan; 47(1):57-61. PubMed ID: 7669403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Significance of blood levels of prolactin and somatotropin as indices of pharmacological effects on the central nervous system].
    Barreca T; Gallamini A; Murialdo G; Nizzo MC; Polleri A
    Clin Ter; 1978 Jul; 86(2):147-59. PubMed ID: 743856
    [No Abstract]   [Full Text] [Related]  

  • 24. Depending on the stimulus, central serotoninergic activation by fenfluramine blocks or does not alter growth hormone secretion in man.
    Casanueva FF; Villanueva L; Peñalva A; Cabezas-Cerrato J
    Neuroendocrinology; 1984 Apr; 38(4):302-8. PubMed ID: 6374488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuropharmacological intervention on the pituitary-hypothalamic relationship.
    Tuomisto J
    Ann Clin Res; 1978; 10(3):120-32. PubMed ID: 31130
    [No Abstract]   [Full Text] [Related]  

  • 26. Endurance exercise modulates levodopa induced growth hormone release in patients with Parkinson's disease.
    Müller T; Welnic J; Woitalla D; Muhlack S
    Neurosci Lett; 2007 Jul; 422(2):119-22. PubMed ID: 17590511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of cholecystokinin octapeptide on the hypothalamic-pituitary-adrenal axis function and on vasopressin, prolactin and growth hormone release in humans.
    Calogero AE; Nicolosi AM; Moncada ML; Coniglione F; Vicari E; Polosa P; D'Agata R
    Neuroendocrinology; 1993 Jul; 58(1):71-6. PubMed ID: 8264858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypothalamic and pituitary dysfunction in obese males.
    Amatruda JM; Hochstein M; Hsu TH; Lockwood DH
    Int J Obes; 1982; 6(2):183-9. PubMed ID: 6807859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypothalamic-pituitary function in diverse hyperprolactinemic states.
    Boyar RM; Kapen S; Finkelstein JW; Perlow M; Sassin JF; Fukushima DK; Weitzman ED; Hellman L
    J Clin Invest; 1974 Jun; 53(6):1588-98. PubMed ID: 4208470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of pyridoxine on human hypophyseal trophic hormone release: a possible stimulation of hypothalamic dopaminergic pathway.
    Delitala G; Masala A; Alagna S; Devilla L
    J Clin Endocrinol Metab; 1976 Mar; 42(3):603-6. PubMed ID: 1254699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Patients with Parkinson disease: functional analysis of dopamine receptors by bromocriptine- thyrotropin-releasing hormone test].
    Díaz F; Liberman C; Chariá P
    Rev Med Chil; 1991 Mar; 119(3):252-7. PubMed ID: 1842116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Place of phenytoin in treatment of resistant epilepsy.
    Rajna P; Veres J; Vitray J
    Ther Hung; 1991; 39(1):30-40. PubMed ID: 1907033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth hormone and prolactin response to levodopa in affective illness.
    Mendlewicz J; Linkowski P; Brauman H
    Lancet; 1977 Mar; 1(8012):652-3. PubMed ID: 66455
    [No Abstract]   [Full Text] [Related]  

  • 34. Growth-hormone and prolactin response to levodopa in affective illness.
    Gold PW; Goodwin FK; Wehr T; Rebar R; Sack R
    Lancet; 1976 Dec; 2(7998):1308-9. PubMed ID: 63787
    [No Abstract]   [Full Text] [Related]  

  • 35. Plasma growth hormone and prolactin response to thyrotropin releasing hormone, L-dopa and luteinizing hormone-releasing hormone in alcoholic patients with liver cirrhosis.
    Zanoboni A; Zanoboni-Muciaccia W; Bonfanti M; Gattei G; Zecca L
    Farmaco Prat; 1980 Sep; 35(9):455-65. PubMed ID: 6778710
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of thyroliberin on the prolactin and thyrotropic and somatotropic hormone content of the blood plasma in insulin-dependent diabetes mellitus].
    Golikova AA
    Probl Endokrinol (Mosk); 1982; 28(5):25-9. PubMed ID: 6815636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Idiopathic hypogonadotrophic hypogonadal primary amenorrhea.
    Kletzky OA; Nicoloff J; Davajan V; Mims R; Mishell DR
    J Clin Endocrinol Metab; 1978 May; 46(5):808-15. PubMed ID: 122290
    [No Abstract]   [Full Text] [Related]  

  • 38. Neuroendocrine aspects in monitoring of dopaminergic drugs in man.
    Hietala J; Koulu M; Scheinin M; Syvälahti E
    Methods Find Exp Clin Pharmacol; 1985 Aug; 7(8):451-4. PubMed ID: 3935892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypothalamic-pituitary-gonadal dysfunction in men using cimetidine.
    Van Thiel DH; Gavaler JS; Smith WI; Paul G
    N Engl J Med; 1979 May; 300(18):1012-5. PubMed ID: 431595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective study between carbamazepine, phenytoin and sodium valproate as monotherapy in previously untreated and recently diagnosed patients with epilepsy.
    Callaghan N; Kenny RA; O'Neill B; Crowley M; Goggin T
    J Neurol Neurosurg Psychiatry; 1985 Jul; 48(7):639-44. PubMed ID: 3928820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.